Sign Up Today and Learn More About Harbinger Health Stock
Invest in or calculate the value of your shares in Harbinger Health or other pre-IPO companies through EquityZen's platform.
Harbinger Health Stock (HAHE)
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
About Harbinger Health Stock
Founded
2018
Headquarters
Cambridge, MA, US
Industries
Software, Data and Analytics, Science and Engineering
Harbinger Health Press Mentions
Stay in the know about the latest news on Harbinger Health
Harbinger Health Announces Data Showcasing Product Innovations of Its Blood-based Platform for Early Cancer Detection
prnewswire • Nov 15, 2024
Harbinger Health Presents Data Demonstrating Novel Capabilities of its Computational Platform to Enhance Performance and Clinical Informativeness in Blood-based Early Cancer Detection
prnewswire • Nov 15, 2024
Harbinger Health Announces New Partnership with Leading Cancer Center to Accelerate Clinical Evidence Generation
prnewswire • Nov 07, 2024
Harbinger Health on LinkedIn: Colorectal cancer is our hidden nemesis, often showing no symptoms until…
linkedin • Apr 06, 2024
Harbinger Health secures $140m funding for cancer platform study
medicaldevice-network • Feb 21, 2024
Harbinger Health Management
Leadership team at Harbinger Health
Chief Commercial Officer
Dymeka Harrison
Chief Business Officer
Mathew Sargent
Join now and verify your accreditation status to gain access to:
- Harbinger Health current valuation
- Harbinger Health stock price
- Available deals in Harbinger Health and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Harbinger Health Stock
How to invest in Harbinger Health stock?
Accredited investors can buy pre-IPO stock in companies like Harbinger Health through EquityZen funds. These investments are made available by existing Harbinger Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Harbinger Health stock?
Shareholders can sell their Harbinger Health stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
